A detailed history of Platinum Investment Management LTD transactions in Exscientia PLC stock. As of the latest transaction made, Platinum Investment Management LTD holds 1,932,204 shares of EXAI stock, worth $9.89 Million. This represents 0.4% of its overall portfolio holdings.

Number of Shares
1,932,204
Previous 3,946,818 51.04%
Holding current value
$9.89 Million
Previous $22.6 Million 56.35%
% of portfolio
0.4%
Previous 0.93%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

SELL
$3.99 - $6.04 $8.04 Million - $12.2 Million
-2,014,614 Reduced 51.04%
1,932,204 $9.85 Million
Q1 2024

May 13, 2024

SELL
$5.3 - $7.51 $749,950 - $1.06 Million
-141,500 Reduced 3.46%
3,946,818 $22.6 Million
Q4 2023

Feb 13, 2024

SELL
$4.35 - $6.88 $1.33 Million - $2.11 Million
-306,740 Reduced 6.98%
4,088,318 $26.2 Million
Q3 2023

Nov 02, 2023

BUY
$4.52 - $8.9 $1.83 Million - $3.61 Million
405,426 Added 10.16%
4,395,058 $19.9 Million
Q2 2023

Aug 10, 2023

BUY
$4.79 - $8.3 $16,338 - $28,311
3,411 Added 0.09%
3,989,632 $23.6 Million
Q1 2023

May 11, 2023

SELL
$5.3 - $10.93 $263,478 - $543,363
-49,713 Reduced 1.23%
3,986,221 $21.1 Million
Q4 2022

Feb 13, 2023

BUY
$4.1 - $8.94 $5.02 Million - $10.9 Million
1,224,814 Added 43.57%
4,035,934 $21.5 Million
Q3 2022

Nov 14, 2022

BUY
$7.27 - $12.92 $5.15 Million - $9.15 Million
708,460 Added 33.69%
2,811,120 $23.1 Million
Q2 2022

Aug 11, 2022

BUY
$6.92 - $15.97 $1.67 Million - $3.86 Million
241,700 Added 12.99%
2,102,660 $22.9 Million
Q1 2022

May 13, 2022

BUY
$11.52 - $22.05 $2.45 Million - $4.69 Million
212,806 Added 12.91%
1,860,960 $26.8 Million
Q4 2021

Feb 11, 2022

BUY
$17.63 - $27.1 $29.1 Million - $44.7 Million
1,648,154 New
1,648,154 $32.6 Million

Others Institutions Holding EXAI

About Exscientia plc


  • Ticker EXAI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 122,461,000
  • Market Cap $627M
  • Description
  • Exscientia plc, an artificial intelligence-driven pharmatech company, engages in discovering, designing, and developing drugs. The company offers end-to-end solution of artificial intelligence (AI) and technologies for target identification, drug candidate design, translational models, and patient selection. In addition, the company focuses on s...
More about EXAI
Track This Portfolio

Track Platinum Investment Management LTD Portfolio

Follow Platinum Investment Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Platinum Investment Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Platinum Investment Management LTD with notifications on news.